🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to evaluate the pharmacokinetics (PK...
Status
Completed
Location
Site 01
Start Date
2023-01-24
Trial ID
NCT05712265
Treatments Being Tested
This study will assess the safety, tolerability, and pharmacokinetics (PK) ...
Status
Completed
Location
Quotient Sciences
Start Date
2020-04-27
Trial ID
NCT04672499
Treatments Being Tested
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study Evaluating t...
Status
Active Not Recruiting
Location
Site #207
Start Date
2023-10-25
Trial ID
NCT06108219
Treatments Being Tested
This optional sub study is a part of the phase 1b, Open-Label Study is to a...
Status
Completed
Location
Site 207
Start Date
2022-03-04
Trial ID
NCT05320146
Treatments Being Tested
A Phase 1b, Open-Label Study Evaluating the Pharmacokinetics and Safety of ...
Status
Recruiting
Location
Site# 433
Start Date
2026-04-30
Trial ID
NCT07553663
Treatments Being Tested
The hypotheses under test are that subjects with alcohol use disorder (AUD)...
Status
Completed
Location
The Scripps Research Institute Pearson Center for Alcoholism and Addiction Research
Start Date
2021-04-15
Trial ID
NCT04466215
Treatments Being Tested
This single-center, randomized, open-label study will assess the relative b...
Status
Completed
Location
Site 01
Start Date
2025-09-11
Trial ID
NCT07240116
This Phase 2, double-blind, placebo-controlled, randomized study is to asse...
Status
Completed
Location
Site #143
Start Date
2020-09-09
Trial ID
NCT04524403
Treatments Being Tested
This phase 2, double blind, placebo-controlled, randomized study is to asse...
Status
Terminated
Location
Site 207
Start Date
2020-11-04
Trial ID
NCT03823703
Treatments Being Tested
This phase 1b, Open-Label Study is to assess the safety, efficacy of mirico...
Status
Completed
Location
Site 207
Start Date
2021-11-23
Trial ID
NCT05117489
Treatments Being Tested